This BPA contract was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 17 to Werfen USA LLC, a manufacturer of in vitro diagnostic equipment, reagents, and services for clinical laboratories and point-of-care settings. The contract has a total ceiling value of $2,000,000 and a period of performance through July 31, 2026. Under this BPA, the VA can issue firm fixed-price task orders for the procurement of coagulation testing equipment, supplies, and...
The key elements of this federal contract Indefinite Delivery Vehicle (IDV) award are as follows: The Department of Veterans Affairs (VA), specifically Veterans Integrated Service Network 6 (VISN 6), awarded a Blanket Purchase Agreement (BPA) to Biomerieux Inc., a global leader in in vitro diagnostics, to provide its proprietary BioFire FilmArray diagnostic systems, associated test kits, and related services. The BPA has a total ceiling value of $6,300,000 and a period of performance through...
This is a Blanket Purchase Agreement (BPA) awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 16 (VISN 16) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, and laboratory equipment. The $1,722,865.60 BPA contract, which does not have a set-aside designation, is for the provision of point-of-care whole blood glucose testing equipment and supplies to VISN 16 facilities across Indiana. The BPA was awarded under...
The U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 6 (VISN 6) awarded a Blanket Purchase Agreement (BPA) to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, to provide BinaxNOW COVID-19 antigen test kits. The BPA, valued at $240,608.97, has an ultimate completion date of September 30, 2024 and was awarded without any set-aside designations. This BPA is part of Abbott Rapid DX North America LLC's Federal Supply Schedule (FSS) 65-VII contract...
This federal contract Indefinite Delivery Vehicle (IDV) is a Blanket Purchase Agreement (BPA) awarded by the Department of Veterans Affairs (VA) to Alba Bioscience, Inc., a subsidiary of Quotient Biodiagnostics, Inc. The BPA, valued at up to $274,627.15, is for the provision of blood bank transfusion reagents to support VA medical facilities under the agency's Veterans Integrated Service Network 19. The contract is not set aside and is awarded under the General Services Administration (GSA)...
Biomerieux Inc., a global leader in in vitro diagnostics, holds a $194 million Federal Supply Schedule contract (FSS-65-VII) with the U.S. federal government for the provision of in-vitro diagnostic products, reagents, and test kits. Under this IDV, Biomerieux has received numerous firm-fixed-price delivery order contracts from agencies such as the Department of Veterans Affairs, Indian Health Service, and Department of Defense to supply its proprietary diagnostic platforms, including the...
The Centers for Disease Control and Prevention (CDC) awarded a Blanket Purchase Agreement (BPA) contract to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, to provide reagents, consumables, and other diagnostic supplies in support of the agency's laboratory testing and disease monitoring capabilities. The $1.25 million single-award contract, issued against the General Services Administration's (GSA) In Vitro Diagnostics, Reagents, and Test (FSS-65-VII) Schedule, has an ultimate...
This Federal Supply Schedule (FSS) contract award to Avmedical LLC is for in-vitro diagnostics, reagents, test kits, and test sets under Schedule 65 VII. The $3,150,000 contract (36F79723D0041) was awarded on December 15, 2022 by the Department of Veterans Affairs and has a 5-year period of performance through December 14, 2027. The contract includes 535 awarded products across multiple Special Item Numbers (SINs) such as chemistry reagents, hematology reagents, microbiology supplies, phlebotomy...
This Federal Supply Schedule (FSS) contract, awarded by the Veterans Integrated Service Network 12 (VISN 12) to Medipurpose, Inc., provides in-vitro diagnostic reagents, test kits, and test sets. The $225,000 multiple-award contract has a performance period extending to March 14, 2025. Medipurpose, Inc., a self-certified small disadvantaged business and manufacturer of goods, was awarded this FSS contract under Schedule 65-VII, which covers in-vitro diagnostics, reagents, and test kits. The...
This is a Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 12 to MHC Medical Products, LLC. The contract is for invitro diagnostics, reagents, test kits, and test sets under FSS-65-VII. The contract has a potential value of $4,800,000.00 and a period of performance from August 1, 2018 to September 1, 2025. The contract was awarded as a multiple award, with no set-asides used. Pricing...